Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 7, 2010, Pages 1775-1783

  Franke, Adrian A ^a   Hebshi, Sandra M ^a   Pagano, Ian ^a   Kono, Naoko ^b   Mack, Wendy J ^b   Hodis, Howard N ^b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; DIHYDRODAIDZEIN; DIHYDROGENISTEIN; EQUOL; FLAVONOID; GENISTEIN; GLYCITEIN; ISOFLAVONOID; O DESMETHYLANGOLENSIN; SOYBEAN PROTEIN; UNCLASSIFIED DRUG; ISOFLAVONE DERIVATIVE; MILK PROTEIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; BLOOD; MIDDLE AGED; NEOPLASMS; URINE;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; MILK PROTEINS; NEOPLASMS; PATIENT COMPLIANCE; PLACEBOS; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 77954523468     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0116     Document Type: Article

References (28)

1. Franke AA, Halm BM, Kakazu K, Li X. Metabolism, bioavailability, and analysis of dietary isoflavones. In: Fraga C, editor. Plant phenolics and human health: biochemistry, nutrition, and pharmacology. Wiley & Sons; 2009.
2. Franke AA, Halm BM, Kakazu K, Li X, Custer L. Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Testing and Analysis 2009;1:14-21.
3. Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006;17:1253-61.
4. Korde LA, Wu AH, Fears T, et al. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 2009;18:1050-9.
5. Shu XO, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001;10:483-8.
6. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-6. (Pubitemid 35012429)
7. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350:990-7.
8. Zheng W, Dai Q, Custer LJ, et al. Urinary excretion of isoflavones and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:35-40.
9. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002;11:815-21.
10. Park SY, Wilkens LR, Franke AA, et al. Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the multiethnic cohort. Br J Cancer 2009;101:185-91.
11. Gu L, House SE, Prior RL, et al. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 2006;136:1215-21.
12. Franke AA, Custer LJ, Hundahl SA. Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 2004;50:141-54.
13. Ritchie MR, Morton MS, Deighton N, Blake A, Cummings JH. Plasma and urinary phyto-oestrogens as biomarkers of intake: validation by duplicate diet analysis. Br J Nutr 2004;91:447-57.
14. Franke AA, Halm BM, Custer LJ, Tatsumura Y, Hebshi S. Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 2006;84:406-13.
15. Franke AA, Halm BM, Ashburn LA. Urinary isoflavones are increased in adults, but decreased in children, consuming soy when on oral antibiotic therapy. Nutr Cancer 2008;60:627-35.
16. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ. Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 1999;47:977-86.
17. Fomon SJ. Nutrition of normal infants. St. Louis: Mosby; 1993.
18. Remer T, Neubert A, Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 2002;75:561-9. (Pubitemid 34174952)
19. Franke AA, Halm B, Ashburn L. Isoflavones in children and adults consuming soy. Arch Biochem Biophys 2008;476:161-70.
20. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 2 - correlation between subjects. BMJ 1995;310:633.
21. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
22. Maskarinec G, Hebshi S, Custer L, Franke AA. The relation of soy intake and isoflavone levels in nipple aspirate fluid. Eur J Cancer Prev 2008;17:67-70.
23. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition - Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
24. Yamamoto S, Sobue T, Sasaki S, et al. Validity and reproducibility of a self-administered food-frequency questionnaire to assess the isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 2001;131:2741-7.
25. Arai Y, Uehara M, Sato Y, et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 2000;10:127-35.
26. Valentin-Blasini L, Blount BC, Caudill SP, Needham LL. Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 2003;13:276-82.
27. Fanti P, Sawaya PB, Custer LJ, Franke AA. Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. J Am Soc Nephrol 1999;40:382-9.
28. Fanti P, Stephenson TJ, Kaariainen IM, et al. Soy food intake and serum levels of soy isoflavones in Japanese, Thai and North American end-stage renal failure patients on chronic hemodialyis therapy. Nephrol Dial Transplant 2003;18:1862-8.